John David Finley - 06 Oct 2025 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role: CEO, CFO, Director
Signature: /s/ Ryker Willie, Attorney-in-Fact
Issuer symbol: PALI
Transactions as of: 06 Oct 2025
Net transactions value: $0
Form type: 4
Filing time: 08 Oct 2025, 17:39:00 UTC
Previous filing: 05 Sep 2025
Next filing: 11 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Finley John David	CEO, CFO, Director	1902 WRIGHT PLACE, SUITE 200, CARLSBAD	/s/ Ryker Willie, Attorney-in-Fact	08 Oct 2025	0001851034

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PALI	Restricted Stock Units	Award	$0	+9,179,400		$0.000000	9,179,400	06 Oct 2025	Common Stock	9,179,400		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.
F2	The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.